Centene CORP Form 4 insider transactions

Paul J Diaz, a Director of Centene Corp, received 2,771 shares of common stock on July 28, 2026.

Lauren M Tyler, a Director of Centene Corp, received 3,155 shares of common stock on July 17, 2026.

Centene Corp. director Lauren M. Tyler acquired 61 shares of common stock on June 30, 2026, through a transaction valued at $0.

Centene Corp. reports a director, Kenneth Tanji, acquired 581 shares of common stock on June 30, 2026.

Centene Corp. Director Theodore R. Samuels II reported the acquisition of 465 shares of common stock on June 30, 2026.

Centene Corp director Frederick H. Eppinger acquired 833 shares of common stock on June 30, 2026, increasing his direct beneficial ownership.

Centene Corp. director Christopher J. Coughlin reported the acquisition of 562 shares of common stock on June 30, 2026.

Susan Raye Smith, Chief Operating Officer of Centene Corp, reported a transaction involving common stock on June 15, 2026.

Centene Corporation Director Kenneth A. Burdick reported the sale of 80,000 shares of common stock at an average price of $64.55.

Michael A. Carson, Group President of Medicare & Specialty at Centene Corp, reported a transaction involving phantom stock units on May 29, 2026.

Michael A. Carson, Group President of Medicare & Specialty at Centene Corp, reported transactions involving common stock and phantom stock.

Centene Corporation Director Kenneth Tanji was granted 3,992 restricted stock units as part of an equity compensation award.

Centene Corporation Director Theodore R. Samuels II was granted 3,992 restricted stock units as part of an equity award.

Centene Corporation director Monte E. Ford acquired 3,992 restricted stock units as part of an equity compensation award.

Centene Corporation Director Frederick H. Eppinger was granted 6,654 restricted stock units as part of an equity award.

Centene Corporation Director James Dallas acquired 3,992 restricted stock units as part of an equity compensation award.

Centene Corporation Director Christopher J. Coughlin was granted 3,992 restricted stock units as part of his compensation.

Centene Corporation Director Kenneth A. Burdick acquired 3,992 shares of common stock via a restricted stock unit grant.

Centene Corporation Director Jessica Blume acquired 3,992 restricted stock units as part of an annual equity award.

Centene Corporation Chief People Officer Tanya McNally reported the withholding of 964 shares to cover tax obligations related to restricted stock unit vesting.

Centene Corp Director Kenneth Tanji acquired 1,179 shares of common stock on March 31, 2026, under a pre-arranged trading plan.

Centene Corp. Director Theodore R. Samuels II acquired 943 shares of common stock on March 31, 2026, increasing his direct beneficial ownership.

Centene Corp. Director Frederick H. Eppinger reported the acquisition of 1,690 shares of common stock, increasing his total beneficial ownership.

Centene Director Coughlin acquires 1,140 common shares.

Centene's Chief Operating Officer, Susan Raye Smith, disclosed a routine disposition of 2,918 common shares for tax withholding purposes following the vesting of restricted stock units.

Centene's Chief People Officer, Tanya M. McNally, reported a pre-planned disposition of 2,785 shares for tax withholding related to restricted stock unit vesting, scheduled for March 15, 2026, under a Rule 10b5-1 plan.

Centene CEO Sarah London reported the sale of 36,061 shares of common stock to cover tax obligations related to vested restricted stock units.

Centene's Secretary and General Counsel, Christopher Koster, reported a disposition of 9,087 common shares for tax withholding purposes related to restricted stock unit vesting.

Centene's Corporate Controller and CAO, Katie Casso, reported the disposition of 3,359 shares of common stock for tax withholding purposes.

Centene's Chief Financial Officer, Andrew Lynn Asher, reported the disposition of 15,241 shares of common stock to cover tax obligations related to restricted stock unit vesting.